术中除三联药物治疗外给予大剂量抗T淋巴细胞球蛋白推注可提高肾移植存活率。 - Suppr | 超能文献

Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.

作者信息

Kaden J, May G, Müller P, Groth J, Strobelt V, Eger E, Wohlfahrt L

机构信息

Department of Laboratory Medicine, Friedrichshain Hospital, Berlin, Germany.

出版信息

Transplant Proc. 1995 Feb;27(1):1060-1.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.术中除三联药物治疗外给予大剂量抗T淋巴细胞球蛋白推注可提高肾移植存活率。

Transplant Proc. 1995 Feb;27(1):1060-1.

2

Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.肾移植术后发生移植肾功能延迟恢复的患者中三种不同抗淋巴细胞诱导方案的比较。

Transplant Proc. 1996 Feb;28(1):400-1.

3

Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.极端年龄的肾移植：环孢素A消除了年龄小于或等于5岁或大于或等于55岁受者中增加的风险。

Transplant Proc. 1994 Oct;26(5):2518-21.

4

Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.对468例采用统一的抗胸腺细胞球蛋白-环孢素序贯疗法的首次尸体肾移植进行单中心分析。

Clin Transpl. 1996:257-64.

5

Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.抗胸腺细胞球蛋白/硫唑嘌呤/环孢素/泼尼松龙四联诱导疗法用于胰肾联合移植受者：8.5年随访结果

Transplant Proc. 2005 May;37(4):1815-7. doi: 10.1016/j.transproceed.2005.02.072.

6

Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation.在吻合完成前通过大剂量单次注射抗胸腺细胞球蛋白进行术中T细胞清除，作为一种改善肾移植术后长期效果的新方法。

Transplant Proc. 1997 Feb-Mar;29(1-2):344-7. doi: 10.1016/s0041-1345(96)00301-6.

7

Prospective randomized study of quadruple versus triple therapy in long-term kidney allografts.长期肾移植中四联疗法与三联疗法的前瞻性随机研究。

Transplant Proc. 1996 Oct;28(5):2819.

8

Predictors of improved outcome in second pediatric renal transplant recipients.

Transplant Proc. 1993 Feb;25(1 Pt 1):597.

9

Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.肾移植中OKT3与抗胸腺细胞球蛋白作为诱导免疫抑制剂的比较。

Transplant Proc. 1996 Jun;28(3):1973-5.

10

Living-related kidney transplantation using low-dose triple immunosuppression.

Transplant Proc. 1994 Aug;26(4):2089.

引用本文的文献

1

Efficacy of anti-T-lymphocyte globulin-Fresenius as an induction agent in deceased-donor renal transplantation: A cohort study.抗淋巴细胞球蛋白-费森尤斯作为尸体供肾移植诱导剂的疗效：一项队列研究。

Exp Ther Med. 2020 Mar;19(3):2384-2390. doi: 10.3892/etm.2020.8451. Epub 2020 Jan 15.

2

Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study.术中给予适度剂量抗胸腺细胞球蛋白在肾移植中安全有效：一项回顾性研究

PeerJ. 2019 Aug 16;7:e7274. doi: 10.7717/peerj.7274. eCollection 2019.

3

Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantation.单剂量大剂量抗胸腺细胞球蛋白诱导疗法预防活体供肾移植排斥反应的长期评估

Int Urol Nephrol. 2008;40(2):515-20. doi: 10.1007/s11255-007-9242-6.